Vaios, Eugene John

Title(s): Assistant Professor of Radiation Oncology

Current Position/Designation: Attending Physician

Institutional Affiliation: Duke University Hospital, The Preston Robert Tisch Brain Tumor Center

Active Email Address: Eugene.vaios@duke.edu

Social Media Handle (Any and/or optional): @EJVaios

Eugene John Vaios, MD, MBA, is an NIH-funded Assistant Professor of Radiation Oncology at the Duke Cancer Institute. He was previously at Harvard University, where he completed his undergraduate and graduate education, as well as his internship at Cambridge Health Alliance. He specializes in the treatment of patients with primary and metastatic brain tumors at the Preston Robert Tisch Brain Tumor Center at Duke, where he is the principal investigator on multiple clinical and translational studies. His NIH-funded research aims to develop non-invasive diagnostic and surveillance strategies for patients with brain tumors in order to accelerate therapeutic discovery and improve clinical outcomes. His interests also include optimizing the integration of radiotherapy with novel systemic agents to minimize treatment-related toxicities and improve tumor control.

Relevant Professional Skills/Experiences

  • Expertise in CNS Radiation Oncology

  • Experience in computational analysis and omics research

  • Background leading correlative biomarker trials

  • Demonstrated leadership leading multi-institutional, international research collaborations

  • Significant contributions to primary and metastatic brain tumor research, funded by the NIH, American Cancer Society, and other institutions

Relevant Career Highlights

  • NIH-funded physician-scientist in the Preston Robert Tisch Brain Tumor Center

  • Assistant Professor of Radiation Oncology, Duke University

  • Principal Investigator for a prospective blood biobanking trial (NCT05480644) for patients with primary and metastatic brain tumors

  • Recipient of multiple prestigious awards, including the RSNA Roentgen Resident/Fellow Research Award

  • Over 30 peer-reviewed publications, including in The Lancet Digital Health, Journal of Clinical Oncology, and JAMA Network Open